Skip to Main Content

Richard Schottenfeld, MD

Senior Research Scientist
DownloadHi-Res Photo

Additional Titles

Affiliated Faculty, Yale Institute for Global Health

About

Titles

Senior Research Scientist

Affiliated Faculty, Yale Institute for Global Health

Biography

Dr Schottenfeld is an experienced clinician, teacher and clinical researcher who has focused on improving the efficacy, accessibility and availability of addictions treatment in the United States and internationally (in Malaysia, Iran and China.) In clinical trials and clinical epidemiologic studies, he has developed new programs that integrate addictions treatment and general medical services and has evaluated the pharmacological and behavioral components of different treatments for opioid dependence and other addictive disorders. In his clinical, administrative and teaching roles, he oversaw development of a multi-component drug abuse treatment program providing innovative ambulatory and residential treatment for addictive disorders and was the founding Director of the Addiction Psychiatry Residency Training Program and the drug abuse clinical research post-doctoral training program at Yale.

Appointments

Education & Training

MD
Yale University (1976)

Research

Overview

My research is aimed at: 1. improving the efficacy of opioid agonist maintenance treatment through investigations of alternatives to methadone for maintenance treatment (e.g., buprenorphine), investigations of adjunctive behavioral (e.g., behavioral drug and HIV risk reduction counseling, BDRC) and pharmacological (e.g., disulfiram) treatments, and developing integrated treatments for co-occurring disorders (co-occurring stimulant abuse or co-occurring chronic pain) for opioid dependent individuals; 2. improving the accessibility and effectiveness of opioid dependence treatment by integrating it in office-based and primary care settings; and 3. expanding opioid dependence treatment and clinical research in international settings (with current projects in Malaysia, Iran, and China). My work on buprenorphine maintenance treatment illustrates the progression of my research. My initial work focused on comparing the efficacy of buprenorphine and methadone for patients with co-occurring cocaine and opioid dependence. Subsequent studies evaluated adjunctive behavioral and pharmacological treatments to improve the effectiveness of buprenorphine maintenance treatment for patients with co-occurring cocaine and opioid dependence and also investigated the effectiveness of buprenorphine maintenance treatment in office-based and primary care settings and strategies for improving its effectiveness in those settings. The studies in office-based and primary care settings, the high prevalence and adverse consequences of chronic pain among opioid dependent patients treated in primary care settings, and the potential advantages of using buprenorphine to treat co-occurring chronic pain and opioid dependence (POD) in these settings led to our current studies aimed at evaluating buprenorphine for POD and at evaluating integrated behavioral treatments for POD. Our studies in primary care settings and physician offices also led to our research aimed at interventions for and treatment of cocaine dependent women identified in prenatal clinics and to our current studies of buprenorphine maintenance treatment in Iran, Malaysia, and China.
  • Combining Behavioral Treatments with Opioid Agonist Maintenance Treatment: In studies in Malaysia, Iran and China, we are evaluating the efficacy and cost-effectiveness of behavioral drug and HIV risk reduction counseling when provided along with methadone or buprenorphine maintenance treatment.
  • Pain and Opioid Dependence: We are evaluating buprenorphine treatment and integrated pain and opioid dependence behavioral therapy for patients with co-occurring chronic pain and opioid dependence.

Medical Subject Headings (MeSH)

Alcoholism; Behavioral Medicine; Buprenorphine; Chronic Pain; Methadone; Opioid-Related Disorders; Substance-Related Disorders

Research at a Glance

Yale Co-Authors

Frequent collaborators of Richard Schottenfeld's published research.

Publications

2008

2006

2005

Academic Achievements & Community Involvement

  • honor

    Nyswander-Dole Award

Clinical Care

Get In Touch

Contacts

Mailing Address

Psychiatry

300 George St

New Haven, CT 06511-

United States

Administrative Support